Effect of HLA matching on the relative risk of mortality for kidney recipients : a comparison of the mortality risk after transplant to the mortality risk of remaining on the waiting list, Clin Transplant, vol.64, issue.9, pp.1274-1277, 1997. ,
The impact of an acute rejection episode on long-term renal allograft survival ,
Immunosuppressive treatments: Mechanisms of action and clinical use, Nephrol ther, issue.7, pp.566-81, 2007. ,
Reexposure to OKT3 in renal allograft recipients, Transplantation, vol.45, pp.349-53, 1988. ,
Comparative antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry, Transplantation, vol.59, pp.1194-1200, 1995. ,
Conversion from mycophenolate mofetil to enteric coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus : clinical, pharmacokinetic, and pharmacodynamic outcomes, Transplantation, vol.83, pp.417-424, 2007. ,
Sirolimus for kaposi's sarcoma in renal transplant recipients, N Engl J Med, vol.352, pp.1317-1340, 2005. ,
A phase I study of a 4 week-course of SDZ-RAD (RAD) quiescent ciclosporine-prednisone-treated renal transplant recipients, Transplantation, vol.68, pp.1100-1106, 1999. ,
Randomized trial of tacrolimus(prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation, Transplantation, vol.69, issue.5, pp.834-875, 2000. ,
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution plus mycophenolate mofetil after cadaveric kidney transplantation : results at 2 years, Transplantation, vol.72, issue.2, pp.245-50, 2001. ,
The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy, Nephrol Dial Transplant, vol.24, issue.7, pp.2269-76, 2009. ,
Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling, British Journal of Clinical Pharmacology, vol.60, issue.3, pp.249-256, 2005. ,
One-year results with extended-release Tacrolimus/MMF, Tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients, Am J Transplant, vol.7, issue.3, pp.595-608, 2007. ,
Reduced exposure to calcineurin inhibitors in renal transplantation, N Engl J Med, vol.357, issue.25, pp.2562-75, 2007. ,
Calcineurin inhibitor minimization in the Symphony study : observational results 3 years after transplantation, Am J Transplant, vol.9, issue.8, pp.1876-85, 2009. ,
Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients, Transplantation Jul, vol.15, issue.721, pp.63-69, 2001. ,
Tacrolimus plus low dose mycophenolate mofetil in renal transplant recipients : better 2 year graft and patient survival than with a higher mycophenolate mofetil dose, Transplant Proc, vol.37, issue.7, pp.3009-3011, 2005. ,
Impact of Mycophenolate Mofetil Loading on Drug Exposure in the Early Posttransplant Period, Transplantation Proceedings, vol.37, pp.2320-2323, 2005. ,
Safety and tolerance of sodium mycophenolate in patients after renal transplantation-an observational study, Transplantation Proceedings, vol.41, pp.3016-3034, 2009. ,
Comparison of inosine-monophosphate-dehydrogenase activity in patients with enteric-coated mycophenolate sodium or mycophenolate mofetil after renal transplantation. Transplant, pp.2524-2532, 2009. ,
Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus based regimens. Transplant Int, Feb, vol.18, issue.2, pp.157-162, 2005. ,
The use of an anti-CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low dose tacrolimus and early withdrawal of steroids in renal transplant recipients, Clin Transplant, vol.17, issue.3, pp.234-241, 2003. ,
Minimization of immunosuppressive therapy after renal transplantation : results of randomized controlled trial, Am J Transplant, vol.5, issue.1, pp.87-95, 2005. ,
Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil and daclizumab induction in renal transplantation, Transplantation, vol.79, issue.7, pp.807-821, 2005. ,
Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/ mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation : results of the Atlas study. Transplantation, pp.1734-1775, 2005. ,
Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation : one year observational results, Clin Transplant, vol.24, issue.1, pp.1-9, 2010. ,
Pharmacokinetics of Tacrolimus : Clinical Relevant Aspects, Transplantation Proceeding, vol.31, pp.21-24, 1999. ,
Pharmacokinetics of FK 506 in Liver Recipients after Continuous Intravenous Infusion, J Clin Pharmacol, vol.33, issue.7, pp.606-617, 1993. ,
Pharmacokinetics, dosing principles, and blood level monitoring of FK 506, Transplant Proc, vol.26, issue.6, pp.3267-3276, 1994. ,
A review of its pharmacology and therapeutic potential in hepatic and renal transplantation, Drugs, vol.46, pp.746-794, 1993. ,
Measurment of FK 506 by HPLC and Isolation and Characterization of Its Metabolites, Transplantation Proceedings, vol.23, issue.1, pp.940-941, 1991. ,
Therapeutic monitoring of tacrolimus, Ann Clin Biochem, vol.35, pp.167-180, 1998. ,
Human P-glycoprotein transports cyclosporin A and FK 506, J Biol Chem, vol.268, pp.6077-6080, 1993. ,
Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients, Ther Drug Monit, vol.31, issue.2, pp.187-97, 2009. ,
A systematic review of the effect of CYP3A5 genotype on the apparent oral clearance of tacrolimus in renal transplant recipients, Ther Drug Monit, vol.32, issue.6, pp.718-732, 2010. ,
Tacrolimus pharmacokinetics and pharmacogenetics : influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms, Fundamental &Clinical Pharmacology, vol.21, pp.427-435, 2007. ,
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression, Nat genet, vol.27, pp.383-91, 2001. ,
CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates : guidelines from an experimental study, Am J Transplant, vol.6, pp.2706-2719, 2006. ,
Dosing tacrolimus based on CYP3A5 genotype : will it improve clinical outcome ?, Clinical phamacol ther, vol.87, issue.6, pp.640-641, 2010. ,
AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients, Kidney int, vol.67, pp.2440-2447, 2005. ,
Tacrolimus whole blood concentrations correlate closely to side effects in renal transplant recipients, J Clin pharmacol, vol.48, pp.445-448, 1999. ,
High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with live rand renal transplants, Ther Drug Monit, vol.19, issue.6, pp.694-700, 1997. ,
Therapeutic Monitoring of Calcineurin Inhibitors for the Nephrologist, Clin J Am Soc Nephrol, vol.2, pp.374-384, 2007. ,
Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine : a report of the FK506 Kidney Transplant Study Group, Transplantation, vol.66, issue.12, pp.1736-1776, 1998. ,
Neurotoxicity after orthotopic liver transplantation, Transplantation, vol.58, issue.2, pp.155-69, 1994. ,
DOI : 10.1097/00007890-199405820-00006
Risk for postransplant diabetes mellitus with current immunosuppressive medications, Am J Kidney Dis, vol.34, issue.1, pp.1-13, 1999. ,
Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study, Transplantation, vol.65, issue.1, pp.87-92, 1998. ,
Phase III study of FK 506 in kidney transplantation, Transplant Proc, vol.27, issue.1, pp.829-862, 1995. ,
FK 506 hepatotoxicity in liver allograft recipients, Transplantation, vol.59, issue.11, pp.1631-1633, 1995. ,
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant, N Engl J Med, vol.341, pp.1725-1755, 1999. ,
Cardiovascular disease after renal transplantation, J Am Soc Nephrol, vol.7, pp.158-65, 1996. ,
Prise en charge médicale des patients greffés rénaux au-delà de la première année post-transplantation, 2008. ,
Multicenter randomized trial comparing tacrolimus (FK506) and ciclosporine in the prevention of renal allograft rejection, a report of the European tacrolimus Multicenter Renal Study Group, Transplantation, vol.64, pp.436-443, 1997. ,
Tacrolimus versus ciclosporine : a favorable vascular risk profile in renal transplant recipients, J Am Soc Nephrol, vol.10, p.736, 1999. ,
Population pharmacokinetics of tacrolimus in adult kidney transplant recipients, Clin Pharmacol Ther, vol.72, issue.6, pp.660-669, 2002. ,
Suivi thérapeutique pharmacologique du tacrolimus : une notion qui change, Therapie, vol.57, issue.2, pp.133-136, 2002. ,
High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation, Nephrol Dial Transplant, vol.25, pp.2757-2763, 2010. ,
Chronic cyclosporine nephropathy : the Achilles'heel of immunosuppressive therapy, Kidney Int, vol.50, pp.1089-100, 1996. ,
Tacrolimus nephrotoxicity : beware of the association of diarrhea, drug interaction and pharmacogenetics, Pediatr Nephrol, 2010. ,
Factors responsible for interindividual variations in dosage/concentration of tacrolimus in renal transplant recipients, Nan Fang Yi Ke Da Xue Xue Bao, vol.28, issue.12, pp.2161-2165, 2008. ,
Distinct effects of omeprazole and rabeprazole on the tacrolimus blood concentration in a kidney transplant recipient, Drug Metab.Pharmacokinet, vol.22, issue.6, pp.441-444, 2007. ,
The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy, J Am Soc Nephrol, vol.14, pp.1046-52, 2003. ,
Early versus late acute renal allograft rejection: impact on chronic rejection, Transplantation, vol.55, issue.5, pp.993-998, 1993. ,
Tacrolimus : review of pharmacokinetics, pharmacodynamics, and pharmacogenetics to facilitate prationners'understanding and offer strategies foe educating patients and promoting adherence, Prog Transplant Sept, vol.19, issue.3, pp.277-84, 2009. ,